Tenders/For patients treated under the program “Treatment of severe growth hormone deficiency in adult patients and adolescents after the growth process has ended”
Awarded🇵🇱PolandSupplies

For patients treated under the program “Treatment of severe growth hormone deficiency in adult patients and adolescents after the growth process has ended”

Auto-translated from Polish
Original title: Dla pacjentów leczonych w ramach programu „ Leczenie ciężkiego niedoboru hormonu wzrostu u pacjentów dorosłych oraz u młodzieży po zakończeniu procesu wzrastania”
Instytut "Pomnik - Centrum Zdrowia Dziecka"
Published: Oct 7, 2026
Updated: Oct 9, 2026
Source: TED - Tenders Electronic Daily (EU)

This tender has been awarded

Awarded to Lek S.A. — €6,270,270

Browse open Health & Medical tenders in Poland

About This Opportunity

This is a supplies contract in the health and medical services sector. Located in Poland, Europe, this opportunity is open to firms and consortiums.

Published through TED - Tenders Electronic Daily (EU), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.

Description

Auto-translated from Polish
1. Recombinant human growth hormone preparation for administration in pens - cartridges (vial/ampoule) less than or equal to (≤7 mg) and cartridges (vial/ampoule) greater than or equal to (≥7 mg) For patients treated under the program “Treatment of severe growth hormone deficiency in adult patients and adolescents after the growth process has ended” 2. Purchase quantity: 134,952 mg 3. The Contracting Authority reserves the right to increase the quantity of the subject of the order, but by no more than 15% of the basic order, in the amount of 20,242 mg. 4. The Contracting Authority anticipates a change in the volume of the subject of the order during the term of the contract, i.e., the possibility of reducing the ordered volume is allowed - by 20% of the basic order volume, in the event of objective and justified needs, in particular changes in demand among patients - this change depends on the internal needs of direct recipients, which may arise during the execution of the order and remains solely at its discretion. The Contractor, by submitting an offer, acknowledges the possibility of various circumstances affecting changes in demand. 5. The offered drug must be registered and reimbursed for the treatment of patients covered by the drug program “Treatment of severe growth hormone deficiency in adult patients and adolescents after the growth process has ended”, financed by the National Health Fund. 6. Pursuant to art. 255 point 3 of the Pzp Act, the Contracting Authority may annul the public procurement procedure if the price or cost of the most advantageous offer or the offer with the lowest price for the basic order exceeds the amount that the Contracting Authority intends to allocate for financing the order. 7. Pursuant to art. 256 of the Pzp Act, the Contracting Authority may annul the procurement procedure before the expiry of the deadline for submitting offers, if circumstances arise that make further conduct of the procedure unjustified. 8. Pursuant to art. 257 of the Pzp Act. The Contracting Authority anticipates the possibility of annulling the public procurement procedure if the funds it intended to allocate for financing all or part of the order have not been granted to it. 8. The order must be executed in accordance with the requirements specified in the SWZ and the Draft Contract Provisions. A detailed description of the subject of the order is specified in the Specification of Conditions of the Order (SWZ). Relevant evidence: Pursuant to art. 105 and art. 106 of the Pzp Act, in order to confirm the compliance of the offered supplies with the requirements, characteristics or criteria specified in the description of the subject of the order or the criteria for evaluating offers or requirements related to the execution of the order, the Contracting Authority requests the Contractors to submit the following documents: • A valid marketing authorization for the medicinal product in the Republic of Poland issued by the President of the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products, or • A valid marketing authorization for the medicinal product issued by the Council of the European Union or the European Commission. 2.2. In the event of failure to attach the relevant evidence mentioned in point 2.1. to the offer, the Contracting Authority, in accordance with art. 107 para. 2 of the Pzp Act. anticipates the possibility of a single supplementation of the aforementioned relevant evidence, within the deadline set by the Contracting Authority. 2.3. The marketing authorization for the medicinal product must be valid and current on the day of submitting the offers. 2.4. The composition of the preparation and packaging must be consistent with the content of the documents referred to in point 2.1. 2.5. In the event that the validity of the document expires, the Contractor is obliged to provide the Contracting Authority with an additional document, along with the documents referred to in point 2.1., declaring the timely submission of an application for extension of the validity of the marketing authorization for the medicinal product or, in the event of its obtaining, a valid marketing authorization for the medicinal product...

Data provenance

This notice is sourced from TED - Tenders Electronic Daily (EU) and was originally published on October 7, 2026. Last refreshed 40 days ago. Original language: Polish. BidsFactory mirrors official procurement notices and links back to the source for full legal text.

About Instytut "Pomnik - Centrum Zdrowia Dziecka"

Instytut "Pomnik - Centrum Zdrowia Dziecka" has issued 8 procurement notices on BidsFactory, including 1 currently open and 3 awarded contracts. Activity concentrates in Health & Medical. All notices are published for Poland. Notices are distributed via TED - Tenders Electronic Daily (EU). Most recent publication: November 12, 2026.

Instytut "Pomnik - Centrum Zdrowia Dziecka": buyer profile, tenders and awards

Frequently asked questions about this tender

How can I submit a bid?

Visit TED - Tenders Electronic Daily (EU) to access the full notice, required documents, and submission instructions provided by the contracting authority.

Is this tender still open?

No — the contract has already been awarded to Lek S.A.. The award notice is archived on BidsFactory for transparency and market intelligence.

Who is the contracting authority?

This notice was issued by Instytut "Pomnik - Centrum Zdrowia Dziecka" in Poland. The authority is responsible for evaluating bids, awarding the contract, and managing performance.

What type of contract is this?

This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.

How much was the contract awarded for?

Lek S.A. was awarded the contract for €6,270,270. The figure reflects the value disclosed by the contracting authority in the award notice.

Where will the contract be performed?

The contract is for delivery in Poland. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.

Find tenders like this automatically

Premium shows the full details of every tender like this one and alerts you instantly when a new one is published.

See plans

Sectors & Categories

Key Details

Contract Type
Supplies
Eligibility
Firms / Consortiums
Language
Polish

Source

ted
TED - Tenders Electronic Daily (EU)
Public Procurement

Contracting Authority

Instytut "Pomnik - Centrum Zdrowia Dziecka"
🇵🇱Poland